Accordingly, in order to obtain mechanistic insights into the combined treatment of GAN and MTX on A549 lung cancer cells, the levels of NF-kB/p65 were estimated using an Enzyme-Linked Immunosorbent Assay (ELISA). This evidence concerns the gene NFKB1 and lung carcinoma.